Skip to content
Latest News
The latest news from Sagent Pharmaceuticals
Filter     Order     Display # 
Date Item Title
Friday, 07 November 2008 Sagent Pharmaceuticals announces presentations at upcoming Lazard Capital Markets and Piper Jaffray Healthcare conferences
Thursday, 09 October 2008 Sagent Pharmaceuticals Inc. and Itochu Chemical Frontier Corporation announce development and manufacturing collaboration
Thursday, 25 September 2008 Sagent Pharmaceuticals acquires rights to multi-chamber syringe technology and launches device division
Thursday, 04 September 2008 Sagent completes $30 million series a financing extension
Friday, 25 July 2008 Sagent Pharmaceuticals launches AMIODARONE HCL INJECTION, USP
Thursday, 24 July 2008 Sagent Pharmaceuticals launches CEFTAZIDIME FOR INJECTION, USP
Wednesday, 16 July 2008 Sagent Pharmaceuticals launches CEFTRIAXONE, USP, and CEFUROXIME FOR INJECTION, USP
Wednesday, 14 May 2008 Sagent Pharmaceuticals provides US$20,000 in aid to earthquake-devastated areas in central China
Thursday, 08 May 2008 Spectrum Pharmaceuticals announces sale of injectable generic drugs to Sagent Pharmaceuticals, Inc.
Monday, 24 March 2008 Sagent Pharmaceuticals launches CEFEPIME FOR INJECTION, USP
Wednesday, 19 March 2008 Sagent Pharmaceuticals launches CIPROFLOXACIN INJECTION, USP, 5% Dextrose Premix Bag
Wednesday, 12 March 2008 Sagent Pharmaceuticals launches CEFAZOLIN FOR INJECTION, USP
Tuesday, 29 January 2008 Sagent Pharmaceuticals Inc. to present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical device conference
Wednesday, 28 November 2007 Sagent Pharmaceuticals launches full-line of prefilled 6 mg and 12 mg ADENOSINE syringes
Monday, 26 November 2007 Sagent Pharmaceuticals, Inc. and Astral Pharmaceutical Industries announce collaboration for developing and manufacturing injectable antibiotics
Tuesday, 30 October 2007 Sagent Pharmaceuticals, Inc. and Strides Arcolab Limited announce collaboration to develop and market more than 25 products in the United States
Sunday, 28 October 2007 Sagent Pharmaceuticals, Inc. to present at CIBC world markets 18th annual healthcare conference
Wednesday, 26 September 2007 Sagent Pharmaceuticals, Inc. completes $53 million series a financing
 
<< Start < Prev 1 Next > End >>
Results 1 - 18 of 18
[ Back ]